TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 62 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $209,000 | -20.2% | 214,898 | -18.2% | 0.00% | – |
Q2 2021 | $262,000 | -90.4% | 262,680 | -90.5% | 0.00% | -100.0% |
Q4 2020 | $2,741,000 | -12.7% | 2,756,000 | -14.8% | 0.01% | -28.6% |
Q3 2020 | $3,139,000 | -7.4% | 3,236,000 | -7.5% | 0.01% | -12.5% |
Q2 2020 | $3,389,000 | +6.5% | 3,500,000 | +1.8% | 0.01% | 0.0% |
Q1 2020 | $3,182,000 | +0.4% | 3,439,000 | +2.9% | 0.01% | +33.3% |
Q4 2019 | $3,168,000 | +355.2% | 3,343,000 | +334.7% | 0.01% | +500.0% |
Q3 2019 | $696,000 | -49.2% | 769,000 | -48.6% | 0.00% | -66.7% |
Q2 2019 | $1,369,000 | -22.6% | 1,497,000 | -22.0% | 0.00% | 0.0% |
Q1 2019 | $1,769,000 | +4.1% | 1,919,000 | +2.0% | 0.00% | -25.0% |
Q4 2018 | $1,699,000 | -6.0% | 1,882,000 | -2.6% | 0.00% | +33.3% |
Q3 2018 | $1,807,000 | -13.7% | 1,932,000 | -14.5% | 0.00% | -25.0% |
Q2 2018 | $2,095,000 | -19.5% | 2,260,000 | -23.9% | 0.00% | 0.0% |
Q1 2018 | $2,603,000 | -17.3% | 2,970,000 | -16.7% | 0.00% | -20.0% |
Q4 2017 | $3,146,000 | +47.3% | 3,565,000 | +82.5% | 0.01% | +25.0% |
Q4 2016 | $2,136,000 | – | 1,953,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ZAZOVE ASSOCIATES LLC | 91,833,000 | $98,950,000 | 5.16% |
Ferox Capital Management LP | 5,390,000 | $5,796,000 | 2.37% |
INCOME RESEARCH & MANAGEMENT | 7,472,000 | $8,014,000 | 2.17% |
SPHERA FUNDS MANAGEMENT LTD. | 14,535 | $8,641,000 | 1.47% |
Lombard Odier Asset Management (Europe) Ltd | 21,660,000 | $23,433,000 | 1.33% |
SHENKMAN CAPITAL MANAGEMENT INC | 11,864,000 | $12,783,000 | 1.15% |
MACKAY SHIELDS LLC | 18,887,000 | $20,335,000 | 0.86% |
AEGON USA Investment Management, LLC | 4,000,000 | $4,290,000 | 0.84% |
ADVENT CAPITAL MANAGEMENT /DE/ | 32,751,000 | $35,196,000 | 0.67% |
PALISADE CAPITAL MANAGEMENT, LP | 6,067,000 | $6,522,000 | 0.24% |